Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome Proliferation

  • Bachovchin, Kelly
  • Díaz, Rosario
  • Ceballos-Pérez, Gloria
  • Rojas-Barros, Domingo I.
  • Pérez-Moreno, Guiomar
  • García-Hernández, Raquel
  • Bosch-Navarrete, Cristina
  • Rivers, Mitch
  • Penn, Erica C.
  • Roncal, Norma E.
  • Sciotti, Richard J.
  • Campbell, Robert F.
  • Martínez-Martínez, María S.
  • Manzano, Pilar
  • Ruiz-Pérez, Luis Miguel
  • Navarro, Miguel
  • González-Pacanowska, Dolores
  • Pollastri, Michael P.
  • Ferrins, Lori
  • Singh, Baljinder
Neglected tropical diseases, such as human African trypanosomiasis (HAT), require novel treatments that can populate the clinical pipeline in the event of rising resistance and treatment recrudescence. Following a high-throughput screen of almost 42,000 human kinase inhibitor chemotypes, we identified a 2,4-disubstituted azaindole that had good antiparasitic activity, selectivity, and predicted brain exposure, but that failed to meet our criteria for advancement into an efficacy study. Following hit-to-lead optimization, we arrived at 18a, which offered the best combination of potency, properties, and pharmacokinetic parameters, and, while not curative, this work leads to opportunities for continued optimization for HAT and cutaneous leishmaniasis., The authors acknowledge funding from the National Institute of Allergy and Infectious Diseases (M.P.P., M.N. D.G.-P., and L.F., 2R01AI114685; M.P.P., 1R21AI127594, R01AI124046), the Spanish Ministerio de Economía, Industria y Competitividad, (M.N., SAF2015-71444 P; D.G.-P., PID2019-109623RB-I00 MICIU/AEI/10.13039/501100011033 and PID2022-142971OB-I00 MCIN/AEI/10.13039/501100011033/ERDF, UE), and Subdirección General de Redes y Centros de Investigación Cooperativa (RICET) (M.N., RD16/0027/0019; D.G.-P., RD16/0027/0014). We thank AstraZeneca for the provision of the in vitro ADME and physicochemical properties data included in the manuscript. Use of JChem/ChemAxon software [Product version 20.11.0, ChemAxon (https://www.chemaxon.com)] is acknowledged., Peer reviewed